166 related articles for article (PubMed ID: 19291308)
1. Implications of the structure of human uridine phosphorylase 1 on the development of novel inhibitors for improving the therapeutic window of fluoropyrimidine chemotherapy.
Roosild TP; Castronovo S; Fabbiani M; Pizzorno G
BMC Struct Biol; 2009 Mar; 9():14. PubMed ID: 19291308
[TBL] [Abstract][Full Text] [Related]
2. Active site conformational dynamics in human uridine phosphorylase 1.
Roosild TP; Castronovo S
PLoS One; 2010 Sep; 5(9):e12741. PubMed ID: 20856879
[TBL] [Abstract][Full Text] [Related]
3. The kinetic mechanism of human uridine phosphorylase 1: Towards the development of enzyme inhibitors for cancer chemotherapy.
Renck D; Ducati RG; Palma MS; Santos DS; Basso LA
Arch Biochem Biophys; 2010 May; 497(1-2):35-42. PubMed ID: 20226755
[TBL] [Abstract][Full Text] [Related]
4. A novel structural mechanism for redox regulation of uridine phosphorylase 2 activity.
Roosild TP; Castronovo S; Villoso A; Ziemba A; Pizzorno G
J Struct Biol; 2011 Nov; 176(2):229-37. PubMed ID: 21855639
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of Escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium.
Caradoc-Davies TT; Cutfield SM; Lamont IL; Cutfield JF
J Mol Biol; 2004 Mar; 337(2):337-54. PubMed ID: 15003451
[TBL] [Abstract][Full Text] [Related]
6. Glycal formation in crystals of uridine phosphorylase.
Paul D; O'Leary SE; Rajashankar K; Bu W; Toms A; Settembre EC; Sanders JM; Begley TP; Ealick SE
Biochemistry; 2010 Apr; 49(16):3499-509. PubMed ID: 20364833
[TBL] [Abstract][Full Text] [Related]
7. Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.
Liu M; Cao D; Russell R; Handschumacher RE; Pizzorno G
Cancer Res; 1998 Dec; 58(23):5418-24. PubMed ID: 9850074
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for inhibition of Escherichia coli uridine phosphorylase by 5-substituted acyclouridines.
Bu W; Settembre EC; el Kouni MH; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):863-72. PubMed ID: 15983408
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.
Pizzorno G; Yee L; Burtness BA; Marsh JC; Darnowski JW; Chu MY; Chu SH; Chu E; Leffert JJ; Handschumacher RE; Calabresi P
Clin Cancer Res; 1998 May; 4(5):1165-75. PubMed ID: 9607574
[TBL] [Abstract][Full Text] [Related]
10. [Research progress on uridine phosphorylase in vertebrate and parasites].
Li RH; Zhu JJ; Yin GR
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Dec; 32(6):465-8. PubMed ID: 25902682
[TBL] [Abstract][Full Text] [Related]
11. Uridine phosophorylase: an important enzyme in pyrimidine metabolism and fluoropyrimidine activation.
Cao D; Pizzorno G
Drugs Today (Barc); 2004 May; 40(5):431-43. PubMed ID: 15319798
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Escherichia coli uridine phosphorylase by single-site mutagenesis.
Oliva I; Zuffi G; Barile D; Orsini G; Tonon G; De Gioia L; Ghisotti D
J Biochem; 2004 Apr; 135(4):495-9. PubMed ID: 15115774
[TBL] [Abstract][Full Text] [Related]
13. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
[TBL] [Abstract][Full Text] [Related]
14. High-syn conformation of uridine and asymmetry of the hexameric molecule revealed in the high-resolution structures of Shewanella oneidensis MR-1 uridine phosphorylase in the free form and in complex with uridine.
Safonova TN; Mikhailov SN; Veiko VP; Mordkovich NN; Manuvera VA; Alekseev CS; Kovalchuk MV; Popov VO; Polyakov KM
Acta Crystallogr D Biol Crystallogr; 2014 Dec; 70(Pt 12):3310-9. PubMed ID: 25478848
[TBL] [Abstract][Full Text] [Related]
15. 19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine.
Holland SK; Bergman AM; Zhao Y; Adams ER; Pizzorno G
Magn Reson Med; 1997 Dec; 38(6):907-16. PubMed ID: 9402191
[TBL] [Abstract][Full Text] [Related]
16. The crystal structure of Streptococcus pyogenes uridine phosphorylase reveals a distinct subfamily of nucleoside phosphorylases.
Tran TH; Christoffersen S; Allan PW; Parker WB; Piskur J; Serra I; Terreni M; Ealick SE
Biochemistry; 2011 Aug; 50(30):6549-58. PubMed ID: 21707079
[TBL] [Abstract][Full Text] [Related]
17. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.
Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S
Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy.
Sommadossi JP; Cretton EM; Kidd LB; McClure HM; Anderson DC; el Kouni MH
Cancer Chemother Pharmacol; 1995; 37(1-2):14-22. PubMed ID: 7497584
[TBL] [Abstract][Full Text] [Related]
19. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine.
Darnowski JW; Handschumacher RE; Wiegand RA; Goulette FA; Calabresi P
Biochem Pharmacol; 1991 Jun; 41(12):2031-6. PubMed ID: 2039551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
